Table 2.
Variables | No. of studies | Homozygous | Heterozygous | Recessive | Dominant | Allele | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
TT versus CC | CT versus CC | TT versus CT/CC | CT/TT versus CC | T versus C | |||||||
OR (95% CI) | phet | OR (95% CI) | phet | OR (95% CI) | phet | OR (95% CI) | phet | OR (95% CI) | phet | ||
All | 68 | 1.64 (1.39–1.94) | <.001 | 1.38 (1.20–1.59) | <.001 | 1.41 (1.23–1.61) | <0.001 | 1.47 (1.27–1.70) | <.001 | 1.37 (1.23–1.52) | <.001 |
Ethnicity | |||||||||||
Asian | 52 | 1.78 (1.48–2.15) | <.001 | 1.51 (1.33–1.70) | <.001 | 1.43 (1.23–1.67) | <0.001 | 1.60 (1.40–1.82) | <.001 | 1.44 (1.29–1.59) | <.001 |
Caucasian | 11 | 1.20 (0.81–1.79) | .007 | 0.79 (0.52–1.21) | <.001 | 1.43 (1.14–1.79) | 0.457 | 0.87 (0.57–1.32) | <.001 | 0.97 (0.72–1.32) | <.001 |
African | 5 | 1.70 (0.63–4.57) | <.001 | 1.88(0.75–4.74) | <.001 | 1.45 (0.62–3.39) | 0.002 | 2.15 (0.86–5.42) | <.001 | 1.92 (0.98–3.73) | <.001 |
HWE | |||||||||||
>0.05 | 52 | 1.76 (1.45–2.13) | <.001 | 1.34 (1.14–1.57) | <.001 | 1.50 (1.29–1.75) | 0.006 | 1.48 (1.26–1.73) | <.001 | 1.39 (1.24–1.56) | <.001 |
≤0.05 | 16 | 1.38 (0.99–1.92) | <.001 | 1.48 (1.11–1.99) | <.001 | 1.19 (0.92–1.55) | <0.001 | 1.44 (1.07–1.95) | <.001 | 1.29 (1.01–1.65) | <.001 |
Quality score | |||||||||||
>9 | 20 | 1.46 (1.12–1.89) | <.001 | 1.29 (0.99–1.69) | <.001 | 1.37 (1.12–1.68) | 0.003 | 1.36 (1.05–1.75) | <.001 | 1.30 (1.09–1.56) | <.001 |
≤9 | 48 | 1.78 (1.43–2.23) | <.001 | 1.42 (1.21–1.67) | <.001 | 1.45 (1.21–1.73) | 0.001 | 1.53 (1.29–1.82) | <.001 | 1.40 (1.23–1.60) | <.001 |
The GenBank reference sequence and version number for the gene is: MTHFR (NM_005957.5). Values were in bold if 95% CIs excluded 1 or p values less than .05.
Abbreviations: CI, confidence interval; Het, heterogeneity; HWE, Hardy–Weinberg equilibrium; OR, odds ratio; T2DM, type 2 diabetes mellitus.